Securities Purchase AgreementSecurities Purchase Agreement • July 18th, 2018 • Cancer Genetics, Inc • Services-medical laboratories • Utah
This Securities Purchase Agreement (this “Agreement”), dated as of July 17, 2018, is entered into by and between Cancer Genetics, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
THIS NOTE AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH...Subordination Agreement • July 18th, 2018 • Cancer Genetics, Inc • Services-medical laboratories • Utah
This Note and the indebtedness evidenced hereby are subordinate in the manner and to the extent set forth in that certain Subordination Agreement (the “SVB Subordination Agreement”) dated as of JULY 17, 2018 by and BETWEEN BORROWER (AS DEFINED BELOW) and SILICON VALLEY BANK to the Senior DEBT (as defined in the SVB Subordination Agreement); and the holder of this Note, by its acceptance hereof, shall be bound by the provisions of the SVB Subordination Agreement.
